Coya Therapeutics Reports Additional Proof-of-Concept Clinical Biomarker Data in Patients with Alzheimers Disease
COYA Stock | 6.09 0.05 0.83% |
About 51% of Coya Therapeutics,'s investor base is interested to short. The analysis of the overall investor sentiment regarding Coya Therapeutics, Common suggests that many traders are impartial. The current market sentiment, together with Coya Therapeutics,'s historical and current headlines, can help investors time the market. In addition, many technical investors use Coya Therapeutics, Common stock news signals to limit their universe of possible portfolio assets.
Coya |
Coya Therapeutics, Inc. , a clinical-stage biotechnology company developing multiple therapeutic platforms int
Read at businesswire.com
Coya Therapeutics, Fundamental Analysis
We analyze Coya Therapeutics,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Coya Therapeutics, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Coya Therapeutics, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
Coya Therapeutics, is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Coya Therapeutics, Common Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Coya Therapeutics, stock to make a market-neutral strategy. Peer analysis of Coya Therapeutics, could also be used in its relative valuation, which is a method of valuing Coya Therapeutics, by comparing valuation metrics with similar companies.
Peers
Coya Therapeutics, Related Equities
LTRN | Lantern Pharma | 20.06 | ||||
GANX | Gain Therapeutics | 15.72 | ||||
TERN | Terns Pharmaceuticals | 11.32 | ||||
STRO | Sutro Biopharma | 2.90 | ||||
INZY | Inozyme Pharma | 2.67 | ||||
DRMA | Dermata Therapeutics | 2.44 | ||||
DAWN | Day One | 1.55 | ||||
HLVX | Hillevax | 0.52 | ||||
CNTA | Centessa Pharmaceuticals | 0.23 | ||||
ELYM | Eliem Therapeutics | 0.31 | ||||
ABOS | Acumen Pharmaceuticals | 0.88 | ||||
TCRX | Tscan Therapeutics | 0.89 | ||||
CGTX | Cognition Therapeutics | 2.56 | ||||
FENC | Fennec Pharmaceuticals | 2.57 | ||||
TFFP | Tff Pharmaceuticals | 3.13 | ||||
OPT | Opthea | 4.24 | ||||
INAB | In8bio | 6.25 | ||||
CUE | Cue Biopharma | 9.65 | ||||
NAMSW | NewAmsterdam Pharma | 14.53 |
Complementary Tools for Coya Stock analysis
When running Coya Therapeutics,'s price analysis, check to measure Coya Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coya Therapeutics, is operating at the current time. Most of Coya Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Coya Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coya Therapeutics,'s price. Additionally, you may evaluate how the addition of Coya Therapeutics, to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Bonds Directory Find actively traded corporate debentures issued by US companies |